2020 Revenues ($USD) : $8,027,000,000
2020 R&D spend : $425,000,000
2020 Number of Employees : 22,000
Fiscal Year End : 12/31/2020
Key People : Joseph C. Papa, CEO

Valeant Pharmaceuticals International changed its name to Bausch Health Companies Inc. in 2018.